Brain Glucose Issues May Signal Alzheimer's Before Amyloid and Tau

Alzheimer's Disease (AD) is a devastating neurodegenerative disorder characterized by progressive memory loss and cognitive decline. Its hallmark pathologies include the accumulation of amyloid-beta plaques and neurofibrillary tangles made of hyperphosphorylated tau protein. While these protein aggregates are well-known, the precise sequence of events leading to AD onset remains unclear, particularly regarding early metabolic changes in the brain.

The review strongly indicates that brain glucose hypometabolism, a reduction in the brain's ability to utilize glucose for energy, is an early and significant event in the progression of Alzheimer's Disease. Evidence suggests this metabolic decline can precede the detectable accumulation of amyloid-beta plaques by as much as 10-15 years and tau pathology by 5-10 years. The most critical finding is that regions of the brain showing reduced glucose uptake often correlate with areas later affected by amyloid and tau accumulation, with metabolic changes observed in up to 80% of individuals with preclinical AD. Specifically, studies showed a 20-30% reduction in glucose metabolism in key brain regions (e.g., temporoparietal cortex) in individuals with mild cognitive impairment compared to healthy controls, even before significant amyloid burden was evident. This metabolic deficit was associated with a 1.5-fold increased risk of developing clinical AD within 5 years.